Reshma, R. ., Jeankumar, V. ., Kapoor, N. ., Saxena, S. ., Bobesh, K. ., Vachaspathy, A. ., … Sriram, D. . (2017). Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. Bioorganic & Medicinal Chemistry, 25(10), 2761-2771. https://doi.org/10.1016/j.bmc.2017.03.053 (Original work published 2017)

Reshma, R. ., Saxena, S. ., Bobesh, K. ., Jeankumar, V. ., Gunda, S. ., Yogeeswari, P. ., & Sriram, D. . (2016). Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors. Bioorganic & Medicinal Chemistry, 24(18), 4499-4508. https://doi.org/10.1016/j.bmc.2016.07.051 (Original work published 2016)

Jeankumar, V. ., Reshma, R. ., Vats, R. ., Janupally, R. ., Saxena, S. ., Yogeeswari, P. ., & Sriram, D. . (2016). Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. European Journal of Medicinal Chemistry, 122, 216-231. https://doi.org/10.1016/j.ejmech.2016.06.042 (Original work published 2016)

Jeankumar, V. ., Saxena, S. ., Vats, R. ., Reshma, R. ., Janupally, R. ., Kulkarni, P. ., … Sriram, D. . (2016). Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain. ChemMedChem, 11(5), 539-48. https://doi.org/10.1002/cmdc.201500556 (Original work published 2016)

Devi, P. ., Sridevi, J. ., Kakan, S. ., Saxena, S. ., Jeankumar, V. ., , … Sriram, D. . (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(6), 786-794. https://doi.org/10.1016/j.tube.2015.04.010

Jeankumar, V. ., Reshma, R. ., Janupally, R. ., Saxena, S. ., Sridevi, J. ., Medapi, B. ., … Sriram, D. . (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)

Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Saxena, S. ., Renuka, J. ., Jeankumar, V. ., Yogeeswari, P. ., & Sriram, D. . Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)

Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Jeankumar, V. ., Renuka, J. ., Kotagiri, S. ., Saxena, S. ., Kakan, S. ., Sridevi, J. ., … Sriram, D. . (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035